Molecular dynamic modeling of CYP51B in complex with azole inhibitors

References

• Aller, A. I., Claro, R., Castro, C., Serrano, C., Colom, M. F., & Martín-Mazuelos, E. (2007). Antifungal susceptibility of Cryptococcus neoformans isolates in HIV-infected patients to fluconazole, itraconazole and voriconazole in Spain: 1994–1996 and 1997–2005. Chemotherapy, 53, 300–305. doi:10.1159/000102585
   PubMed Web of Science ®Google Scholar
• Aoyama, Y. (2005). Recent progress in the CYP51 research focusing on its unique evolutionary and functional characteristics as a diversozyme P450, 10, 1546–1557.
   Google Scholar
• Bellamine, A., Mangla, A. T., Nes, W. D., & Waterman, M. R. (1999). Characterization and catalytic properties of the sterol 14-demethylase from Mycobacterium tuberculosis. Proceedings of the National Academy of Sciences, 96, 8937–8942. doi:10.1073/pnas.96.16.8937.
   PubMed Web of Science ®Google Scholar
• Case, D. A., Darden, T. A., Cheatham, T. E. III, Simmerling, C. L., Wang, J., Duke, R., … Merz, K. M. (2010). AMBER 11, 117, 439–445.
   Google Scholar
• Conner, K. P., Woods, C. M., & Atkins, W. M. (2011). Interactions of cytochrome P450s with their ligands. Archives of Biochemistry and Biophysics, 507, 56–65. doi:10.1016/j.abb.2010.10.006
   PubMed Web of Science ®Google Scholar
• Cui, Y. L., Zhang, J. L., Zheng, Q. C., Niu, R. J., Xu, Y., Zhang, H. X., & Sun, C. C. (2013). Structural and dynamic basis of human cytochrome P450 7B1: A survey of substrate selectivity and major active site access channels. Chemistry – A European Journal, 19, 549–557. doi:10.1002/chem.201202627
   PubMed Web of Science ®Google Scholar
• Cui, Y. L., Zheng, Q. C., Zhang, J. L., Xue, Q., Wang, Y., & Zhang, H. X. (2013). Molecular dynamic investigations of the mutational effects on structural characteristics and tunnel geometry in CYP17A1. Journal of Chemical Information and Modeling, 53, 3308–3317. doi:10.1021/ci400553w
   PubMed Web of Science ®Google Scholar
• Dundas, J., Ouyang, Z., Tseng, J., Binkowski, A., Turpaz, Y., & Liang, J. (2006). CASTp: Computed atlas of surface topography of proteins with structural and topographical mapping of functionally annotated residues. Nucleic Acids Research, 34, W116–W118. doi:10.1093/nar/gkl282
   PubMed Web of Science ®Google Scholar
• Fan, J. R., Zheng, Q. C., Cui, Y. L., Li, W. K., & Zhang, H. X. (2015). Investigation of ligand selectivity in CYP3A7 by molecular dynamics simulations. Journal of Biomolecular Structure and Dynamics, 33, 2360–2367. doi:10.1080/07391102.2015.1054884
   PubMed Web of Science ®Google Scholar
• Hargrove, T. Y., Wawrzak, Z., Lamb, D. C., Guengerich, F. P., & Lepesheva, G. I. (2015). Structure-functional characterization of cytochrome P450 sterol 14α-demethylase (CYP51B) from Aspergillus fumigatus and molecular basis for the development of antifungal drugs. Journal of Biological Chemistry, 290, 23916–23934. doi:10.1074/jbc.M115.677310
   PubMed Web of Science ®Google Scholar
• Hou, T., Xu, Z., Zhang, W., McLaughlin, W. A., Case, D. A., Xu, Y., & Wang, W. (2009). Characterization of domain-peptide interaction interface: A generic structure-based model to decipher the binding specificity of SH3 domains. Molecular & Cellular Proteomics, 8, 639–649. doi:10.1074/mcp.M800450-MCP200
   PubMed Web of Science ®Google Scholar
• Humphrey, W., Dalke, A., & Schulten, K. (1996). VMD: Visual molecular dynamics. Journal of Molecular Graphics, 14, 33–38.10.1016/0263-7855(96)00018-5
   PubMed Web of Science ®Google Scholar
• Ji, H., Zhang, W., Zhang, M., Kudo, M., Aoyama, Y., Yoshida, Y., … Zhou, Y. (2003). Structure-based de novo design, synthesis, and biological evaluation of non-azole inhibitors specific for lanosterol 14α-demethylase of fungi. Journal of Medicinal Chemistry, 46, 474–485.10.1021/jm020362c
   PubMed Web of Science ®Google Scholar
• Lee, M. S., Salsbury, F. R., & Brooks, C. L. (2002). Novel generalized Born methods. The Journal of Chemical Physics, 116, 10606–10614. doi:10.1063/1.1480013
   Web of Science ®Google Scholar
• Lepesheva, G. I., & Waterman, M. R. (2004). CYP51 – the omnipotent P450. Molecular and Cellular Endocrinology, 215, 165–170. doi:10.1016/j.mce.2003.11.016
   PubMed Web of Science ®Google Scholar
• Lepesheva, G. I., & Waterman, M. R. (2007). Sterol 14α-demethylase cytochrome P450 (CYP51), a P450 in all biological kingdoms. Biochimica et Biophysica Acta (BBA) – General Subjects, 1770, 467–477. doi:10.1016/j.bbagen.2006.07.018
   PubMed Web of Science ®Google Scholar
• Li, W., Tang, Y., Liu, H., Cheng, J., Zhu, W., & Jiang, H. (2008). Probing ligand binding modes of human cytochrome P450 2J2 by homology modeling, molecular dynamics simulation, and flexible molecular docking. Proteins: Structure, Function, and Bioinformatics, 71, 938–949. doi:10.1002/prot.21778
   PubMed Web of Science ®Google Scholar
• Lorbek, G., Lewinska, M., & Rozman, D. (2012). Cytochrome P450s in the synthesis of cholesterol and bile acids – from mouse models to human diseases. FEBS Journal, 279, 1516–1533. doi:10.1111/j.1742-4658.2011.08432.x
   PubMed Web of Science ®Google Scholar
• Lupetti, A., Danesi, R., Campa, M., Del, T. M., & Kelly, S. (2002). Molecular basis of resistance to azole antifungals. Trends in Molecular Medicine, 8, 76–81.10.1016/S1471-4914(02)02280-3
   PubMed Web of Science ®Google Scholar
• Mellado, E., Diaz-Guerra, T. M., Cuenca-Estrella, M., & Rodriguez-Tudela, J. L. (2001). Identification of two different 14-sterol demethylase-related genes (cyp51A and cyp51B) in Aspergillus fumigatus and other Aspergillus species. Journal of Clinical Microbiology, 39, 2431–2438. doi:10.1128/JCM.39.7.2431-2438.2001
   PubMed Web of Science ®Google Scholar
• Park, S., Khalili-Araghi, F., Tajkhorshid, E., & Schulten, K. (2003). Free energy calculation from steered molecular dynamics simulations using Jarzynski’s equality. The Journal of Chemical Physics, 119, 3559–3566.10.1063/1.1590311
   Web of Science ®Google Scholar
• Petřek, M., Otyepka, M., Banáš, P., Košinová, P., Koča, J., & Damborský, J. (2006). CAVER: A new tool to explore routes from protein clefts, pockets and cavities. BMC Bioinformatics, 7, 316. doi:10.1186/1471-2105-7-316
   PubMed Web of Science ®Google Scholar
• Saravolatz, L. D., Johnson, L. B., & Kauffman, C. A. (2003). Voriconazole: A new triazole antifungal agent. Clinical Infectious Diseases, 36, 630–637.
   PubMed Web of Science ®Google Scholar
• Sen, K., & Hackett, J. C. (2009). Molecular oxygen activation and proton transfer mechanisms in lanosterol 14α-demethylase catalysis. The Journal of Physical Chemistry B, 113, 8170–8182.10.1021/jp902932p
   PubMed Web of Science ®Google Scholar
• Tyzack, J. D., Williamson, M. J., Torella, R., & Glen, R. C. (2013). Prediction of cytochrome P450 xenobiotic metabolism: Tethered docking and reactivity derived from ligand molecular orbital analysis. Journal of Chemical Information And Modeling, 53, 1294–1305. doi:10.1021/ci400058s
   PubMed Web of Science ®Google Scholar
• Waterman, M. R., & Lepesheva, G. I. (2005). Sterol 14α-demethylase, an abundant and essential mixed-function oxidase. Biochemical and Biophysical Research Communications, 338, 418–422. doi:10.1016/j.bbrc.2005.08.118
   PubMed Web of Science ®Google Scholar
• Yoshida, Y., Aoyama, Y., Noshiro, M., & Gotoh, O. (2000). Sterol 14-demethylase P450 (CYP51) provides a breakthrough for the discussion on the evolution of cytochrome P450 gene superfamily. Biochemical and Biophysical Research Communications, 273, 799–804. doi:10.1006/bbrc.2000.3030
   PubMed Web of Science ®Google Scholar
• Zonios, D. I., & Bennett, J. E. (2008). Update on azole antifungals. Seminars in respiratory and critical care medicine, 29, 198–210. doi:10.1055/s-2008-1063858
   PubMed Web of Science ®Google Scholar